期刊文献+

靶向Pin1基因的shRNA干扰质粒的构建及其对大肠癌SW620细胞Pin1基因的抑制作用 被引量:2

Construction of shRNA Interfering Plasmid Targeting Pin1 Gene and Its Inhibitory Effect on Pin1 Gene of Colon Cancer SW620 Cells
原文传递
导出
摘要 目的构建靶向Pin1基因的短发夹RNA(shRNA)干扰真核表达质粒,并检测其对大肠癌SW620细胞Pin1基因的抑制作用。方法设计合成特异性针对人Pin1基因的寡核苷酸序列,退火后与pGenesil-1载体连接,构建靶向Pin1基因的shRNA真核表达质粒pGenesil-1-Pin1(+),利用脂质体转染大肠癌SW620细胞,以质粒pGenesil-1-Pin(-)转染细胞和未转染细胞为对照。利用荧光显微镜观察转染后细胞表达的绿色荧光蛋白,估算转染效率;应用实时荧光定量PCR和Western blot检测其对SW620细胞Pin1基因mRNA转录及蛋白表达的影响。结果所构建的特异Pin1shRNA真核表达质粒经酶切及测序证明构建正确,转染SW620细胞的转染效率为64%。shRNA对SW620细胞Pin1基因mRNA的抑制率在转染后72h最高,为70.2%,蛋白抑制率为60%。结论已成功构建了靶向Pin1基因的shRNA干扰真核表达质粒,可抑制SW620细胞Pin1基因mRNA的转录及蛋白的表达。 Objective To construct the short hairpin RNA(shRNA) interfering plasmid targeting Pin1 gene and determine its inhibitory effect on the Pinl gene of colon cancer SW620 cells. Methods The oligonueleotide sequence specific to human Pinl gene was designed and synthesized then, after annealing, inserted into vector pGenesil-1. The constructed shRNA eukaryotic expression vector pGenesil-1-Pinl (+) was transfeeted to SW620 cells in mediation of liposome, using the SW620 cells transfected with plasmid pGenesil-l-Pinl(-) and the untransfected SW620 cells as controls. The green fluorescent protein (GFP) expressed in transfeeted cells were observed by fluorescent microscopy, based on which the transfection efficacy was calculated. The effects of plasmid pGene- sil-l-Pin 1 (+) on the transcription of Pin1 mRNA and expression of Pin l protein in SW620 cells were determined by real-time fluorescent quantitative PCR and Western blot. Results Both restriction analysis and sequencing proved that shRNA eukaryotic expression vector pGenesil-l-Pinl (+) was constructed correctly. The transfection efficacy of SW620 cells with pGenesil-l-Pinl (+) was 64%. The inhibiting rate on transcription of Pin1 mRNA in SW620 cells reached a peak value (70. 2%) 72 h after transfection with plasmid pGenesil-l-Pinl(+), while that on expression of Pinl protein was 60%. Conclusion The shRNA interfering plasmid targeting Pinl gene was successfully constructed, which inhibited the transcription of Pinl mRNA and expression of Pinl protein in SW620 cells.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第3期213-216,共4页 Chinese Journal of Biologicals
基金 山西省科技攻关项目(2006031087-02)
关键词 Pin1基因 RNA干扰 短发夹RNA 大肠癌 Pinl gene RNA interfering Short hairpin RNA(shRNA) Colon cancer
  • 相关文献

参考文献21

  • 1Zheng H, You H, Zhou X Z, et al. The prolyl isomerase Pinl is a regulator of p53 in genotoxic response. Nature, 2002, 419 (6909): 849-853.
  • 2Ryo A, Liou YC, Lu KP, et al. Prolyl isomerase Pinl: a catalyst for oncogenesis and a potential therapeutic target in cance. J Cell Sci, 2003, 116 (5): 773-783.
  • 3Yaffe MB, Schutkowski M, Shen MZ, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science, 1997, 278: 1957-1960.
  • 4Kuramochi J, Arai T, Ikeda S, et al. High Pinlexpression is associated with tumor progression in eolorectal cancer. J Surg Oncol, 2006, 94 (2): 155-160.
  • 5刘菊英,周建农,陈森清,张彤,莫伏根,束永前.Pin1在结直肠癌中过表达及其与β-catenin关系的研究[J].南京医科大学学报(自然科学版),2007,27(10):1138-1142. 被引量:1
  • 6Xu YX, Manley JL. The prolyl isomerase Pinl functions in mitotic chromosome condensation. Mol Cell, 2007, 26(20): 287-300.
  • 7Bain JR, Schisler JC, Takeuchi K, et al. An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. Diabetes, 2004, 53: 2190-2194.
  • 8蒋菊香,马珍妮,胡晓慧,董宁征,阮长耿.实时定量PCR分析MT1-MMP/TIMP-2/MMP-2在不同来源人血管内皮细胞株中的表达[J].中国血液流变学杂志,2007,17(1):7-10. 被引量:2
  • 9Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature, 1998, 391 ( 6669 ): 806 - 811.
  • 10McManus MT, Haines BB, Dillon CP, et al. Small interfering RNA mediated gene silencing in T lymphoeytes 1. J Immunol, 2002, 169 (10): 5754-5760.

二级参考文献23

  • 1李红雨,马丁.肿瘤发生的催化分子——肽基脯氨酰顺反异构酶Pin1[J].医学分子生物学杂志,2005,2(4):292-294. 被引量:4
  • 2Chang-Jae Kim,Yong-Gu Cho,Yong-Gyu Park,Suk-Woo Nam,Su-Young Kim,Sug-Hyung Lee,Nam-Jin Yoo,Jung-Young Lee,Won-Sang Park,Young-Mok Yang.Pin1 overexpression in colorectal cancer and its correlation with aberrant β-catenin expression[J].World Journal of Gastroenterology,2005,11(32):5006-5009. 被引量:8
  • 3萨姆布鲁克 金冬雁等(译).分子克隆实验指南(第2版)[M].北京:科学出版社,1992..
  • 4Xu Y X, Hirose Y, Zhou X Z, et al. Pinning down transcription: regulation of RNA polymerase Ⅱ activity during the cell cycle [J]. Cell Cycle, 2004,3(4):432-435.
  • 5Bao L, Kimzey A, Santer G, et al. Prevalent overexpression of prolyl isomerase Pinl in human cancers [J]. Am J Pathol,2004,164(5) : 1727-1737.
  • 6Wuff G M, Ryo A, Wuff G G, et al. Pinl is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene [J]. EMBO J, 2001,20( 13 ) : 3459-3472.
  • 7Wulf G, Garg P, Liou Y C, et al. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pinl in tumorigenesis [ J ]. EMBO J, 2004,23 (16) :3397-3407.
  • 8Ayala G, Wang D, Wulf G, et al. Pinl is a novel prognostic marker in prostate cancer [J]. Cancer Res, 2003,63 (19) :6244-6251.
  • 9Miyashita H, Mori S, Motegi K, et al. Pinl is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression [J]. Oncol Rep, 2003,10(2) :455-461.
  • 10Lu K P. Pinning down cell signaling, cancer and Alzheimer's disease [ J ]. Trends Biochem Sci, 2004,29 (4) : 200-209.

共引文献19

同被引文献25

  • 1Jacque JM, Triques K, Stevenson M. Modulation of HIV-I replication by RNA interference [J]. Nature, 2002, 418 (6896): 435-438.
  • 2Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression replication by RNA interference [J], Hepatology, 2003, 37 (4): 764-770.
  • 3Liu G, Ding W, Liu X, et al. c-Fos is required for TGFbetal production and the associated paracrine migratory effects of human colon carcinoma cells [J]. Mol Carcinog, 2006, 45 (8): 582-593.
  • 4Durchdewald M, Angel P, Hess J. The transcription factor Fos: a Janus-type regulator in health and disease [J]. Histol Histopathol, 2009, 24 (11): 1451-1461.
  • 5Baan B, Pardali E, ten Dijke P, et al. In situ proximity ligation detection of c-Jun / AP-I dimers reveals increased levels of c-Jun / Fral complexes in aggressive breast cancer cell lines in vitro and in vivo [J]. Mol Cell Proteomics, 2010, 9 (97): 1982-1990.
  • 6Zhu YT, Hu L, Qi C, et al. PRIP promotes tumor tormation through enhancing serum-responsive factor-mediated FOS expression [J]. J Biol Chem, 2009, 284 (21): 14485-14492.
  • 7Rao DD, Senzer N, Cleary MA, et al. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development [J]. Cancer Gene Ther, 2009, 16 ( 11 ): 807-809.
  • 8Wang SL, Yao HH, Qin ZH. Strategies for short hairpin RNA delivery in cancer gene therapy [J]. Expert Opin Biol Ther, 2009, 9 (11): 1357-1365.
  • 9Bangsow C,Rubins N,Glusman G,et al.The RUNX3 gene--se-quence,structure and regulated expression[J].Gene,2001,279(2):221-232.
  • 10Chen W,Gao N,Shen Y,et al.Hypermethylation downregulatesRunx3 gene expression and its restoration suppresses gastric ep-ithelial cell growth by inducing p27 and caspase3 in human gastriccancer[J].J Gastroenterol Hepatol 2010,25(4):823-831.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部